NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

Mutations of the NRAS and TP53 genes and internal tandem duplication (ITD) of the FLT3 gene are among the most frequently observed molecular abnormalities in the myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We sought to determine the incidence of these abnormalities in patients...

Full description

Bibliographic Details
Main Authors:	Fidler, C, Watkins, F, Bowen, D, Littlewood, T, Wainscoat, J, Boultwood, J
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021-10-01)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1995)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2003)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
by: Čolović Nataša, et al.
Published: (2023-01-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
by: Lijuan Zhang, et al.
Published: (2023-12-01)

Gene expression profiling in the myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2005)

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Thomas Cluzeau, et al.
Published: (2021-09-01)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
by: Haase, D, et al.
Published: (2019)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
by: Bernard, E, et al.
Published: (2020)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
by: Y. Fang, et al.
Published: (2022-06-01)

Clonality in the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2001)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)

<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic Syndromes
by: Mariko Yabe, et al.
Published: (2021-11-01)

Molecular pathogenesis of the myelodysplastic syndromes
by: Boultwood, J, et al.
Published: (1999)

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
by: Boultwood, J, et al.
Published: (1993)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
by: Boultwood, J, et al.
Published: (1994)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
by: Boultwood, J, et al.
Published: (1993)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
by: Daver, NG, et al.
Published: (2022)

How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Michael Loschi, et al.
Published: (2022-09-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
by: Doolittle, H
Published: (2017)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1997)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
by: Pellagatti, A, et al.
Published: (2004)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
by: Fidler, C, et al.
Published: (1999)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

<i>TP53</i> in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
by: Cosimo Cumbo, et al.
Published: (2020-05-01)

Mutation analysis of the SPARC gene in the 5q-syndrome.
by: Fidler, C, et al.
Published: (2000)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
by: Boultwood, J, et al.
Published: (1991)

The 5q-syndrome.
by: Boultwood, J, et al.
Published: (1994)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
by: Wang, L, et al.
Published: (2007)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
by: Lewis, S, et al.
Published: (1995)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
by: Fernandez-Mercado, M, et al.
Published: (2013)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
by: Boultwood, J, et al.
Published: (2000)

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
by: Youshan Zhao, et al.
Published: (2022-06-01)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
by: Pellagatti, A, et al.
Published: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
by: Pellagatti, A, et al.
Published: (2005)